Skip to content

Bioventus Inc.

BVS

CIK 0001665988

← back to feed
Revenue (TTM)
$542.28M
−0.9% YoY Q1 Mar 2026
Net Income (TTM)
$11.09M
+162.9% YoY Q1 Mar 2026
EPS Diluted (TTM)
$0.16
+158.9% YoY Q1 Mar 2026
Gross Margin
68.3%
Q1 Mar 2026
Operating Margin
7.9%
Q1 Mar 2026
Net Margin
2.0%
Q1 Mar 2026
Free Cash Flow (TTM)
−$19.16M
Q1 Mar 2026
Cash
$35.85M
Q1 Mar 2026
Total Debt
$272.08M
Q1 Mar 2026
Shares Outstanding
—
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings